Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5204085
Max Phase: Preclinical
Molecular Formula: C26H26F2N4O2S
Molecular Weight: 496.58
Associated Items:
ID: ALA5204085
Max Phase: Preclinical
Molecular Formula: C26H26F2N4O2S
Molecular Weight: 496.58
Associated Items:
Canonical SMILES: CCn1cc(NC(=O)OCc2ccc(F)c(F)c2)c2cc(-c3nc(CN4CCCC4)cs3)ccc21
Standard InChI: InChI=1S/C26H26F2N4O2S/c1-2-32-14-23(30-26(33)34-15-17-5-7-21(27)22(28)11-17)20-12-18(6-8-24(20)32)25-29-19(16-35-25)13-31-9-3-4-10-31/h5-8,11-12,14,16H,2-4,9-10,13,15H2,1H3,(H,30,33)
Standard InChI Key: LTVZBBDNQWJASD-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 496.58 | Molecular Weight (Monoisotopic): 496.1745 | AlogP: 6.41 | #Rotatable Bonds: 7 |
Polar Surface Area: 59.39 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 12.28 | CX Basic pKa: 7.50 | CX LogP: 5.63 | CX LogD: 5.28 |
Aromatic Rings: 4 | Heavy Atoms: 35 | QED Weighted: 0.32 | Np Likeness Score: -2.15 |
1. Lei H, Cao Z, Wu H, Li T, Wang X, Chen Y, Ma E, Sun L, Zhai X.. (2022) Structural and PK-guided identification of indole-based non-acidic autotaxin (ATX) inhibitors exhibiting high in vivo anti-fibrosis efficacy in rodent model., 227 [PMID:34742015] [10.1016/j.ejmech.2021.113951] |
Source(1):